D'AgatiV.Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol2003;23:117–134.
2.
PavenstadtH, KrizW, KretzlerM.Cell biology of the glomerular podocyte. Physiol Rev2003;83:253–307.
3.
KarleSM, UetzB, RonnerV, Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol2002;12:388–393.
4.
KimJM, WuH, GreenG, CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science2003;300:1298–1300.
5.
CoventryS, ShoemakerLR. Collapsing glomerulopathy in a 16-year-old girl with pulmonary tuberculosis: the role of systemic inflammatory mediators. Ped Dev Pathol2004;7:166–170, DOI: 10.1007/s10024-003-3027-4.
6.
SavinVJ, SharmaR, SharmaM, Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med1996;334:878–883.
7.
MathiesonPW. What has the immune system got against the glomerular podocyte. Clin Exp Immunol2003;134:1–5.
8.
BarisoniL, KoppJB. Modulation of podocyte phenotype in collapsing glomerulopathies. Microsc Res Tech2002;57:254–262.
